Valuation: Zynex, Inc.

Market Cap 3.83M 3.35M 3.11M 2.86M 5.39M 369M 5.47M 37.1M 14.52M 181M 14.37M 14.06M 625M P/E 2023
40.3x
P/E 2024 89x
Enterprise Value 38.02M 33.31M 30.93M 28.42M 53.55M 3.67B 54.34M 368M 144M 1.8B 143M 140M 6.2B EV / Sales 2023
2.17x
EV / Sales 2024 1.5x
Free-Float
38.37%
Yield 2023 *
-
Yield 2024 -
1 day+5.77%
6 months-31.16%
Current year-56.35%
Current year 0.02
Extreme 0.0203
0.13
1 year 0.02
Extreme 0.0203
2.82
3 years 0.02
Extreme 0.0203
13.77
5 years 0.02
Extreme 0.0203
17.25
10 years 0.02
Extreme 0.0203
27.02
Manager TitleAgeSince
Chief Executive Officer 53 2025-08-17
Director of Finance/CFO 50 2025-08-17
General Counsel 53 2025-08-17
Director TitleAgeSince
Director/Board Member 50 2026-03-25
Director/Board Member 53 2026-03-25
Date Insider Type Main position Quantity % Market Cap.
3/26/26 Issuer sale

Director

95,000 0.3126%
3/26/26 Issuer sale

Director

80,001 0.2633%
3/26/26 Issuer sale

Director

102,000 0.3357%
Change 5-day change 1-year change 3-year change Capi.($)
+5.77%-.--%-97.75%-99.40% 1.69M
+0.57%-1.65%+23.11%-6.36% 195B
+0.07%-10.78%-5.67%-29.99% 126B
-2.68%-12.41%-33.33%+1.20% 124B
-0.51%-0.16%-58.35%-19.17% 64.2B
-0.21%-3.32%+10.58%-8.86% 48.68B
+0.17%-0.52%-24.32%-32.66% 43.83B
+0.45%-0.93%+14.86%+4.58% 37.52B
+0.89%-1.09%+29.00%+28.44% 36.09B
-0.86%+1.99%+87.07%+0.20% 29.13B
Average +0.66%-5.35%-5.48%-16.20% 70.38B
Weighted average by Cap. +0.20%-5.03%-0.72%-9.59%

Financials

2023 2024
Net sales 184M 162M 150M 138M 260M 17.79B 263M 1.79B 699M 8.7B 692M 677M 30.06B 192M 169M 156M 144M 271M 18.56B 275M 1.86B 730M 9.08B 722M 707M 31.37B
Net income 9.73M 8.53M 7.92M 7.27M 13.71M 939M 13.91M 94.3M 36.91M 460M 36.53M 35.75M 1.59B 2.99M 2.62M 2.44M 2.24M 4.22M 289M 4.28M 29.01M 11.36M 141M 11.24M 11M 488M
Net Debt 31.59M 27.68M 25.7M 23.61M 44.49M 3.05B 45.15M 306M 120M 1.49B 119M 116M 5.15B 34.19M 29.96M 27.81M 25.56M 48.16M 3.3B 48.87M 331M 130M 1.61B 128M 126M 5.58B
Logo Zynex, Inc.
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
Employees
1,000
  1. Stock Market
  2. Stocks
  3. ZYXI Stock